American doctors have now discovered the injections put users at 'significantly higher' risk compared to three other common diabetes drugs.
Novo Nordisk A/S, GE HealthCare Technologies Inc. Read MarketBeat.com (Jea Yu)'s latest article on Investing.com ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback